Coccidioidomycosis during pregnancy: A review and recommendations for management

Clinical Infectious Diseases

Volumn 53, Issue 4, 2011, Pages 363-368

  Bercovitch, Robert S ^a   Catanzaro, Antonino ^a   Schwartz, Brian S ^b   Pappagianis, Demosthenes ^c   D Heather Watts, ^d   Ampel, Neil M ^e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CYTOCHROME P450 REDUCTASE; FLUCONAZOLE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE; PYRROLE; STEROL 14ALPHA DEMETHYLASE; VORICONAZOLE;

AMNION FLUID; ANTLEY BIXLER SYNDROME; ARACHNOIDITIS; AUTOPSY; BREAST FEEDING; CAUSE OF DEATH; CELLULAR IMMUNITY; CLEFT PALATE; COCCIDIOIDOMYCOSIS; CONGENITAL DISORDER; CONGENITAL MALFORMATION; CRANIOFACIAL SYNOSTOSIS; CUSHING SYNDROME; DELIVERY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INHIBITION; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; ECHOGRAPHY; EMBRYO DEVELOPMENT; EPIDEMIC; ERYTHEMA NODOSUM; FETUS OUTCOME; FETUS WASTAGE; GENE MUTATION; HUMAN; HYPOPLASIA; IMMUNE RESPONSE; LIVE BIRTH; LOW BIRTH WEIGHT; LOW DRUG DOSE; MATERNAL DISEASE; MATERNAL MORTALITY; MEDICAL HISTORY; MENINGITIS; MORTALITY; NONHUMAN; PATIENT CARE; PLACENTA; PREGNANCY; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PUBLISHING; PUERPERIUM; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; SPONTANEOUS ABORTION; STEROL METABOLISM; TERATOGENICITY; THIRD TRIMESTER PREGNANCY; UNITED STATES; UNSPECIFIED SIDE EFFECT; VAGINA CANDIDIASIS; VAGINA SECRETION; VAGINAL DELIVERY;

ANIMALS; ANTIFUNGAL AGENTS; COCCIDIOIDOMYCOSIS; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 79961221685     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir410     Document Type: Review

References (73)

1. Farness OJ. Coccidioidomycosis. J Am Med Assoc 1941; 116:1749-52.
2. Smale LE, Birsner JW. Maternal deaths from coccidioidomycosis. J Am Med Assoc 1949; 140:1152-4.
3. Vaughan JE, Ramirez H. Coccidioidomycosis as a complication of pregnancy. Calif Med 1951; 74:121-5.
4. Smale LE, Waechter KG. Dissemination of coccidioidomycosis in pregnancy. Am J Obstet Gynecol 1970; 107:356-61.
5. Wack EE, Ampel NM, Galgiani JN, Bronnimann DA. Coccidioidomycosis during pregnancy. An analysis of ten cases among 47, 120 pregnancies. Chest 1988; 94:376-9.
6. Caldwell JW, Arsura EL, Kilgore WB, Garcia AL, Reddy V, Johnson RH. Coccidioidomycosis in pregnancy during an epidemic in California. Obstet Gynecol 2000; 95:236-9. (Pubitemid 30045646)
7. Arsura EL, Kilgore WB, Ratnayake SN. Erythema nodosumin pregnant patients with coccidioidomycosis. Clin Infect Dis 1998; 27:1201-3. (Pubitemid 29242470)
8. Mendenhall JC, Black WC, Pottz GE. Progressive (disseminated) coccidioidomycosis during pregnancy. Rocky Mt Med J 1948; 45:472-6.
9. Cohen R, Burnip R. Coccidioidin skin testing during pregnancy and in infants and children. Calif Med 1950; 72:31-3.
10. Baker RL. Pregnancy complicated by coccidioidomycosis; report of two cases. Am J Obstet Gynecol 1955; 70:1033-8.
11. Harrison HN. Fatal maternal coccidioidomycosis; a case report and review of sixteen cases from the literature. Am J Obstet Gynecol 1958; 75:813-20.
12. Harris RE. Coccidioidomycosis complicating pregnancy. Report of 3 cases and review of the literature. Obstet Gynecol 1966; 28:401-5.
13. Hadsall FJ, Acquarelli MJ. Disseminated coccidioidomycosis presenting as facial granulomas in pregnancy: a report of two cases and a review of the literature. Laryngoscope 1973; 83:51-8.
14. VanBergen WS, Fleury FJ, Cheatle EL. Fatal maternal disseminated coccidioidomycosis in a nonendemic area. Am J Obstet Gynecol 1976; 124:661-3.
15. McCoy MJ, Ellenberg JF, Killam AP. Coccidioidomycosis complicating pregnancy. Am J Obstet Gynecol 1980; 137:739-40. (Pubitemid 10035918)
16. Peterson CM, Johnson SL, Kelly JV, Kelly PC. Coccidiodal meningitis and pregnancy: a case report. Obstet Gynecol 1989; 73:835-6. (Pubitemid 19113442)
17. Walker MP, Brody CZ, Resnik R. Reactivation of coccidioidomycosis in pregnancy. Obstet Gynecol 1992; 79:815-7.
18. Hooper JE, Lu Q, Pepkowitz SH. Disseminated coccidioidomycosis in pregnancy. Arch Pathol Lab Med 2007; 131:652-5. (Pubitemid 46564445)
19. Arnold CA, Rakheja D, Arnold MA, et al. Unsuspected, disseminated coccidioidomycosis without maternofetal morbidity diagnosed by placental examination: case report and review of the literature. Clin Infect Dis 2008; 46:e119-23. (Pubitemid 351706791)
20. Mongan ES. Acute disseminated coccidioidomycosis. Am J Med 1958; 24:820-2.
21. Peterson CM, Schuppert K, Kelly PC, Pappagianis D. Coccidioidomycosis and pregnancy. Obstet Gynecol Surv 1993; 48:149-56. (Pubitemid 23063099)
22. Crum NF, Ballon-Landa G. Coccidioidomycosis in pregnancy: case report and review of the literature. Am J Med 2006; 119:993 e11-17.
23. Spinello IM, Johnson RH, Baqi S. Coccidioidomycosis and pregnancy: a review. Ann N Y Acad Sci 2007; 1111:358-64. (Pubitemid 47573012)
24. Singh N, Perfect JR. Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis 2007; 45:1192-9. (Pubitemid 47580319)
25. Ampel NM. Measurement of cellular immunity in human coccidioidomycosis. Mycopathologia 2003; 156:247-62. (Pubitemid 37506804)
26. Dodge RR, LebowitzMD, Barbee R, Burrows B. Estimates of C. immitis infection by skin test reactivity in an endemic community. Am J Public Health 1985; 75:863-5. (Pubitemid 15236297)
27. Smith CE, Saito MT, Beard RR, Kepp RM, Clark RW, Eddie BU. Serological tests in the diagnosis and prognosis of coccidioidomycosis. Am J Hyg 1950; 52:1-21.
28. Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev 1990; 3:247-68.
29. Townsend TE, McKey RW. Coccidioidomycosis in infants. AMA Am J Dis Child 1953; 86:51-3.
30. Christian JR, Sarre SG, Peers JH, Salazar E, De Rosario J. Pulmonary coccidioidomycosis in a twenty-one-day-old infant; report of a case and review of the literature. AMA Am J Dis Child 1956; 92:66-74.
31. Hyatt HW Sr. Coccidioidomycosis in a 3-week-old infant. Am J Dis Child 1963; 105:93-8.
32. Shafai T. Neonatal coccidioidomycosis in premature twins. Am J Dis Child 1978; 132:634.
33. Bernstein DI, Tipton JR, Schott SF, Cherry JD. Coccidioidomycosis in a neonate; maternal-infant transmission. J Pediatr 1981; 99:752-4. (Pubitemid 12229150)
34. Charlton V, Ramsdell K, Sehring S. Intrauterine transmission of coccidioidomycosis. Pediatr Infect Dis J 1999; 18:561-3. (Pubitemid 29277628)
35. Linsangan LC, Ross LA. Coccidioides immitis infection of the neonate: two routes of infection. Pediatr Infect Dis J 1999; 18:171-3.
36. Purtilo DT. Opportunistic mycotic infections in pregnant women. Am J Obstet Gynecol 1975; 122:607-10.
37. Spark RP. Does transplacental spread of coccidioidomycosis occur? Report of a neonatal fatality and review of the literature. Arch Pathol Lab Med 1981; 105:347-50. (Pubitemid 11065854)
38. Cohen R. Placental coccidioides; proof that congenital coccidioides is nonexistent. Arch Pediatr 1951; 68:59-66.
39. Larwood TE. Maternal fetal transmission of coccidioidomycosis. In: Wayne LE, ed. Transactions of the seventh Veterans Administration-Armed Forces Coccidioidomycosis Study Group. Washington, DC: Veterans Administration, 1962;28-9.
40. Fiese MJ. Treatment of disseminated coccidioidomycosis with amphotericin B: report of a case. Calif Med 1957; 86:119-20.
41. Brass C, Galgiani JN, Campbell SC, Stevens DA. Therapy of disseminated or pulmonary coccidioidomycosis with ketoconazole. Rev Infect Dis 1980; 2:656-60.
42. Tucker RM, Denning DW, Dupont B, Stevens DA. Itraconazole therapy for chronic coccidioidal meningitis. Ann Intern Med 1990; 112:108-12. (Pubitemid 20022690)
43. Galgiani JN, Catanzaro A, Cloud GA, et al. Fluconazole therapy for coccidioidalmeningitis. The NIAID-Mycoses Study Group. Ann Intern Med 1993; 119:28-35.
44. Lee BE, Feinberg M, Abraham JJ, Murthy AR. Congenital malformations in an infant born to a woman treated with fluconazole. Pediatr Infect Dis J 1992; 11:1062-4.
45. Antley R, Bixler D. Trapezoidocephaly, midfacial hypoplasia and cartilage abnormalities with multiple synostoses and skeletal fractures. Birth Defects Orig Artic Ser 1975; 11:397-401.
46. Aleck KA, Bartley DL. Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. Am J Med Genet 1997; 72:253-6. (Pubitemid 27424225)
47. Lopez-Rangel E, Van Allen MI. Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype. Birth Defects Res A Clin Mol Teratol 2005; 73:919-23. (Pubitemid 41739255)
48. Pursley TJ, Blomquist IK, Abraham J, Andersen HF, Bartley JA. Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis 1996; 22:336-40. (Pubitemid 26056165)
49. Inman W, Pearce G, Wilton L. Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy. Eur J Clin Pharmacol 1994; 46:115-8. (Pubitemid 24101326)
50. Mastroiacovo P, Mazzone T, Botto LD, et al. Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. Am J Obstet Gynecol 1996; 175:1645-50. (Pubitemid 27021041)
51. Sørensen HT, Nielsen GL, Olesen C, et al. Risk of malformations and other outcomes in children exposed to fluconazole in utero. Br J Clin Pharmacol 1999; 48:234-8. (Pubitemid 29349461)
52. De Santis M, Di Gianantonio E, Cesari E, Ambrosini G, Straface G, Clementi M. First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy. Drug Saf 2009; 32:239-44.
53. Tiboni GM, Giampietro F. Murine teratology of fluconazole: evaluation of developmental phase specificity and dose dependence. Pediatr Res 2005; 58:94-9. (Pubitemid 40967436)
54. Krcmery V Jr, Huttova M, Masar O. Teratogenicity of fluconazole. Pediatr Infect Dis J 1996; 15:841.
55. Campomori A, Bonati M. Fluconazole treatment for vulvovaginal candidiasis during pregnancy. Ann Pharmacother 1997; 31:118-9. (Pubitemid 27030079)
56. Amado JA, Pesquera C, Gonzalez EM, Otero M, Freijanes J, Alvarez A. Successful treatment with ketoconazole of Cushing's syndrome in pregnancy. Postgrad Med J 1990; 66:221-3. (Pubitemid 20083082)
57. Boronat M, Marrero D, López-Plasencia Y, Barber M, Schamann Y, Nó voa FJ. Successful outcome of pregnancy in a patient with Cushing's disease under treatment with ketoconazole during the first trimester of gestation. Gynecol Endocrinol 2010; doi:10.3109/09513590.2010. 521268.
58. Tiboni GM. Second branchial arch anomalies induced by fluconazole, a bis-triazole antifungal agent, in cultured mouse embryos. Res Commun Chem Pathol Pharmacol 1993; 79:381-4. (Pubitemid 23095812)
59. Menegola E, Broccia ML, Di Renzo F, Giavini E. Antifungal triazoles induce malformations in vitro. Reprod Toxicol 2001; 15:421-7. (Pubitemid 32758396)
60. Strushkevich N, Usanov SA, Park HW. Structural basis of human CYP51 inhibition by antifungal azoles. J Mol Biol 2010; 397:1067-78.
61. Schmidt K, Hughes C, Chudek JA, et al. Cholesterol metabolism: the main pathway acting downstream of cytochrome P450 oxidoreductase in skeletal development of the limb. Mol Cell Biol 2009; 29:2716-29.
62. Adachi M, Tachibana K, Asakura Y, Yamamoto T, Hanaki K, Oka A. Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome. Am J Med Genet A 2004; 128A:333-9. (Pubitemid 38988634)
63. Flück CE, Tajima T, Pandey AV, et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 2004; 36:228-30. (Pubitemid 38282745)
64. Janssen Pharmaceuticals. Sporonox→ (itraconazole) U.S. product information. 2010.
65. Schering Corporation. Noxafil→ (posaconazole) U.S product information. 2010.
66. Pfizer Corporation. VFend→ (voriconazole) U.S. product information. 2010.
67. Itraconazole. In: Briggs GG, Freeman RK, Yaffe SJ, eds. Drugs in pregnancy and lactation a reference guide to fetal and neonatal risk, 6th ed. Baltimore, MD: LipincottWilliams & Wilkins, 2002; 744-6/i.
68. Fluconazole. In: Briggs GG, Freeman RK, Yaffe SJ, eds. Drugs in pregnancy and lactation a reference guide to fetal and neonatal risk, 6th ed. Baltimore, MD: LipincottWilliams & Wilkins, 2002; 553-8/f.
69. Njoku JC, Gumeel D, Hermsen ED. Antifungal therapy in pregnancy and breast feeding. Curr Fungal Infect Rep 2010; 4:62-9.
70. Moretti ME, Ito S, Koren G. Disposition of maternal ketoconazole in breast milk. Am J Obstet Gynecol 1995; 173:1625-6.
71. Force RW. Fluconazole concentrations in breast milk. Pediatr Infect Dis J 1995; 14:235-6.
72. Transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108:776-89.
73. Dewsnup DH, Galgiani JN, Graybill JR, et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med 1996; 124:305-10. (Pubitemid 26047456)